Abstract
Accelerated weight loss, associated with a decrease in body fat and skeletal muscle mass characterizes the metabolic response to catabolic illness. While these events are commonly observed in patients who have sustained extensive injury or severe infection, similar responses have been described in individuals with other disorders such as multiple organ systems failure, patients with chronic obstructive lung disease, those with AIDS and individuals undergoing extensive chemotherapy and radiation treatment for cancer.1
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Wilmore DW. Catabolic illness, strategies for enhancing recovery. NEJ Med 1991;325:695–702.
Streat SJ, Beddoe AH, Hill GL. Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients. J Trauma 1987;27:262–266.
Loder PB, Smith RC, Kee AJ, et al. What rate of infusion of intravenous nutrition solution is required to stimulate uptake of amino acids by peripheral tissues in depleted patients? Ann Surg 1990;211:360–368.
Arnold I, Eden E, Lundholm K. The inefficiency of total parenteral nutrition to stimulate protein synthesis in moderately malnourished patients.Ann Surg1982;208:M3–49.
Ross RJM, Miell J, Freeman E, et al. Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin like growth factor-1. Clin Endocrinol 1991;35:47–54.
Nygren J, Sammann M, Malm M, et al. Disturbed anabolic hormonal patterns in burned patients: the relation to glucagon. Clin Endocrinol 1995;43:491–500.
Van Den Berghe G, De Zegher F, Lauwers P, Veldhuis JD. Growth hormone secretion in critical illness: effect of dopamine. J Clin Endocrinol Metab 1994;79:1141–1146.
Ho KY, Veldhuis JD, Johnson ML, et al. Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. J Clin Endocrinol Metab 1988;81:968–975.
Ross RJM and Chew SL. Acquired growth hormone resistance. European J Endo 1995;132:655–660.
Ross RJM, Miell JP, Holly JMP, et al. Levels of GH and IGF binding proteins, insulin, blood glucose and cortisol in intensive care patients. Clin Endocrinol 1991;35:361–367.
Holly JMP, Claffey DCP, Cwyfan-Hughes SC, et al. Proteases acting on IGFBPs; their occurrence and physiological significance. Growth Reg 1993;3:88–91.
Miell JP, Taylor AM, Jones J, et al. Administration of human recombinant insulin-like growth factor-1 to patients following major gastrointestinal surgery. Clin Endocrinol 1992;37:542–551.
Herndon DN, Barrow RE, Kunkel KR. Effect of recombinant human growth hormone on donor-site healing in severely burned children. Ann Surg 1990;212:424–429.
Hermansson M, Wickelgren RB, Hammargvist F, et al. Measurement of human growth hormone receptor messenger ribonucleic acid by a quantitative polymerase chain reaction-based assay: demonstration of reduced expression after elective surgery. J Clin Endo and Metab 1997;82:421–428.
Ward HC, Halliday D, Sim JW. Protein and energy metabolism and biosynthetic human growth hormone after gastrointestinal surgery. Ann Surg 1987;206:56–61.
Vara-Thorbeck R, Guerrero JA, Ruiz-Requena E, Garcia-Carriazo M. Can the use of growth hormone reduce the postoperative fatigue syndrome. World J. Surg 1996;20:81–86.
Byrne TA, Morrissey TB, Gatzen, et al. Anabolic therapy with growth hormone accelerates protein gain in surgical patients requiring nutritional rehabilitation. Ann Surg 1993;218:400–418.
Jauch KW, Hermann A, Hart W, et al. Dose-dependent effects of human growth hormone (rHGH) on postoperative substrate metabolism. Clin Nutr 1992;11:9(Supp, Abstr).
Wilmore DW, Moylan JA, Briston BP, et al. Anabolic effects of human growth hormone and high caloric feedings following thermal injury. Surg Gynec Obst 1974;138:875–884.
Peterson SR, Haladay NJ, Jeevanandam M. Enhancement of protein synthesis efficiency (PSE) in parenterally fed trauma victims by adjuvant recombinant human growth hormone. J Trauma 1994;36:726–733.
Ziegler TR, Young LS, Ferrari-Balioiera E. Use of human growth hormone combined with nutritional support in a critical care unit. JPEN 1990;14:574–581.
Shernan SK, Demling RH, LaLonde C, et al. Growth hormone enhanced reepithelialization of human split-thickness skin graft donor sites. Surg. Forum 1989;40:37–39.
Herndon DN, Barrow RE, Kunkle KR, et al. Effects of recombinant human growth hormone on donor site healing in severely burned children. Ann Surg 1990;212:424–429.
Herndon DN, Hawkins HK, Nguyen TT et al. Characterization of growth hormone enhanced donor site healing in patients with large cutaneous burns. Ann Surg 1995;221:649–656.
Koea JB, Breier BH, Douglas RG, et al. Anabolic and cardiovascular effects of recombinant human growth hormone in surgical patients with sepsis. Brit J Surg 1996;83:196–202.
Pope GS, Friedman M, Underwood LE, et al. The effect of growth hormone on weight gain and pulmonary function in patients with chromc obstructive lung disease. CHEST 1991;99:1495–1500.
Pichard C, Jolliet P, Chevrolet JC, et al. Recombinant human growth hormone in chronic and acute respiratory insufficiency. Hormonal Research 1996;46:222–229.
Knor JP, Wilmore DW, Demling RH, et al. Use of growth hormone for postoperative respiratory failure. Am J Surg 1996;171:576–580.
Knox JB, Demling RH, Wilmore DW, et al. Hypercalcemia associated with the use of human growth hormone in an adult surgical intensive care unit. Arch Surg 1995;130:442–445.
Schambelan M, Mulligan K, Grunfeld C, et al. Recombinant human growth hormone in patients with HIV-associated wasting. Ann Intern Med 1996;125:873–882.
Garibotto G, Barreca A, Russo R, et al. Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients. J Clin Invest 1997;99:97–105.
Wilmore DW, Lacey JM, Soultanakis RP, et al. Factors predicting a successful outcome after pharmacologic bowel compensation. Ann Surg, in press.
Knox JB, Demling RH, Wllmore DW, et al. Hypercalcemia associated with the use of human growth hormone in an adult surgical intensive care unit. Arch Surg 1995;130:442–445.
Schambelan M, Mulligan K, Grunfeld C, et al. Recombinant human growth hormone in patients with HIV-associated wasting. Ann Intern Med 1996;125:873–882.
Garibotto G, Barreca A, Russo R, et al. Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients. J Clin Invest 1997;99:97–105.
Wilmore DW, Lacey JM, Soultanakis RP, et al. Factors predicting a successful outcome after pharmacologic bowel compensation. Ann Surg, in press.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Wilmore, D. (1999). GH and Catabolic States. In: Bengtsson, BÅ. (eds) Growth Hormone. Endocrine Updates, vol 4. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5163-8_21
Download citation
DOI: https://doi.org/10.1007/978-1-4615-5163-8_21
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7351-3
Online ISBN: 978-1-4615-5163-8
eBook Packages: Springer Book Archive